Stocks · Health care · Services-Medical Laboratories

VERACYTE, INC.

VCYT Clue Score73
United States Fiscal year ends December CIK 0001384101 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

By person

15 insiders · 3 transactions
30.8×

Marc Stapley holds 30.8 times base salary in stock. $21.61M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $50.00, the price Common Stock was last bought or sold at on the open market here, on 27 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Karin Eastham
Director
—
$742.57K (1) scheduled
−$742.57K
10,247
0.0127%
$512.40K
−69.2%
Jens Holstein
Director
—
$375.00K (1) scheduled
−$375.00K
27,471
0.0342%
$1.37M
−1.5%
Muna Bhanji
Director
—
$81.46K (1) scheduled
−$81.46K
40,854
0.0508%
$2.04M
+18.2%
Marc Stapley
Chief Executive Officer
—
—
—
432,073
0.5375%
$21.61M
+34.7%
Rebecca Chambers
Chief Financial Officer
—
—
—
166,025
0.2065%
$8.30M
+18.8%
Phillip G. Febbo
Chief Scientific & Med Officer
—
—
—
133,048
0.1655%
$6.65M
+42.9%
Annie McGuire
EVP, General Counsel
—
—
—
131,160
0.1632%
$6.56M
+38.1%
John Leite
Global Chief Commercial Off
—
—
—
124,329
0.1547%
$6.22M
+63.2%
Robert S Epstein
Director
—
—
—
57,718
0.0718%
$2.89M
+29.4%
Eliav Barr
Director
—
—
—
56,461
0.0702%
$2.82M
+34.9%
Kevin Richard Haas
Chief Dev and Tech Officer
—
—
—
44,221
0.0550%
$2.21M
—
Jonathan Wygant
VP, Chief Accounting Officer
—
—
—
41,920
0.0521%
$2.10M
−15.1%
Evan/ Fa Jones
Director
—
—
—
34,634
0.0431%
$1.73M
+0.8%
David Brent Shafer
Director
—
—
—
31,100
0.0387%
$1.56M
+88.4%
Thomas F. Miller
Director
—
—
—
31,100
0.0387%
$1.56M
+88.4%